Phase 2 data show significant reductions in nausea and vomiting that can cause patients to discontinue GLP-1s.
While many patients experience common side effects from GLP-1 medications — such as nausea and bloating, new research has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback